Drug Promotional Literature – A Critical Appraisal in a Tertiary Care Teaching Hospital in Eastern India

Author:

Shekhar Dr Amritanshu,Roushan Dr Ravi,Mishra Dr Hitesh,Hameed Dr Saajid,Mohan Dr Lalit,Dikshit Dr Harihar

Abstract

Drug promotional literatures (DPLs) are pamphlets or brochures printed by various pharmaceutical companies in order to promote the sale of products manufactured by them. DRPs can be highly informative and may contribute to practice of evidence-based medicine if it provides the true information including important drawbacks and if they are considered after critical analysis and review. But in most of the cases, they are misleading. Therefore, DPLs have to be critically analyzed for their content to prevent irrational prescribing pattern. This study was carried out to critically analyze the information content of drug advertisements in drug promotional literature available to the Medical Practitioners. Collected DPLs were assessed as per the WHO guidelines. Other additional analysis was also done such as whether cost was mentioned or not, validity, credibility and year of reference to scientific literature and picture or flowchart printed on the DPL. The data collected was summarized form using Microsoft Excel 365. Descriptive analysis was done to analyze and compare the data using percentages. A total of 543 DPLs were collected out of which only 393 were analyzed as per our inclusion and exclusion criteria. 213 (54.20%) DPLs were based on single drug formulation while 180 (45.80%) DPLs were on FDC. Drugs acting on cardiovascular system, antidiabetics and antimicrobials were among the top three groups of promoted drugs, indicating that drug companies are targeting diseases that are widespread. Approximately 70% of DPLs met only half of WHO's criteria for rational drug promotion. Based on the observations of this study, it is recommended that clinicians should be aware of the shortcomings in promotional literature before accepting it as source of valid information. When using drugs, especially new drugs on patients, the clinician should carefully analyze the results of research and draw conclusions, since misleading and incorrect information is now often found in promotional literature.

Publisher

Global Research Online

Subject

Pharmaceutical Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3